{"name":"Molecular Templates, Inc.","slug":"molecular-templates-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":3395000,"revenueGrowth":80.6,"grossMargin":0,"rdSpend":48875000,"netIncome":-8124000,"cash":11523000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE8tU1B4Um1TVEFGRllwZTMwYXBlWEM4N21NQ19KanRHTkRRYWxlSHI4Q0swRktwdjZXaUVDSWg1emswVDh2ZkZmUm9WTThPckU5TGdNbkRmVnFpWGhVamc?oc=5","date":"2026-04-03","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxORHIxUlJaY2NsZGZBc0JyYVBMLXZHdGFfa19VZ05lTkxna3RMYjZnSEZudnVuWVRrUUM0R3phUmgydGprYjNYMkw2TXk2UXlfY1VRY3ptTjgtZ0NOT09NTkdvaV9ySGhxRWgxSGRPTTRYeGZJcUprVXBOdHFTeHZEMnBaSk1tRHl0QmtwNEtIekJpMnlKb3Y5UkxiT3ZZV2RnY1ExalNjQXVlT2JHblBVNjR0RWU4MEZtUG1FcHJ2VTRKSkkxVnVBbXlSQV9EdmNIQm9TSzE2eWF0NDFPM2l4eGFjdUQ3Uk5WRVBIRVExWmpSNXI2TG5jaGtUS1J3R28zektDbWZkS3VudTJSQ2d2MA?oc=5","date":"2026-02-12","type":"pipeline","source":"PR Newswire","summary":"BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | DelveInsight - PR Newswire","headline":"BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUVd3eHp6dEdjN3BZaTZiR3VpVktqVE9WZnNzb3B1ZEpMY3RDZ0pzV1FvSndvYXJxU2F6LXdQcXlmZHd5dEpuTUhjdG5pWHNwSU1iQVlJZDlsY3d3cmxqanozWVdfd0NYc19BaDZ3VlVkVXBjeXp2cjBIOWNqYVd2QVV5ZzhISHRaeUQyUlFrSjdHZUZMci1COWdOZ1FTdUFfQ2lFcXRZNjFHRTNfNG5IYW4taGVVcTdWVnRrYVZjbw?oc=5","date":"2025-10-03","type":"pipeline","source":"Eyes On Eyecare","summary":"Leadership watch: KALA BIO names new CEO, Aurion Biotech promotes execs - Eyes On Eyecare","headline":"Leadership watch: KALA BIO names new CEO, Aurion Biotech promotes execs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxQaExka3owSnh2ZUpIWUs1UWdiY052UlRCOWlYcFota0N5SEtILVlZTktnbkJZZmhuSS1HMTg1T1NuMXlzcWh4MXg0UnhSWG9Gd0tnVnk4dXlVUUlWMTVDX29rWDFWRmxRRks4MWx3LXhSdTJxaG9ZR1RKZUp1WTJoTkFjNEhuMDJHVF9uZ2hZMUtKb2pjWkxoY1R3dldISE9LcGdHdmhudWdwQ1FWX0wyUVp5cnpBNDlqX0tqbVV3YUtvQXpqM1RoZjZUb3IweFhlVzJlNmZvYjR0bVJzeFpfS1Q3M2pXOXgtR1FJRWpGT3BJSjhQZjNnMnhxdVNFQ3N2Y3Jva1k0YTNKVzNabnJBS2dmazYwbDNrVjlvSmh4WkZZZk9RcjFLSF9sYlFZdw?oc=5","date":"2025-09-04","type":"pipeline","source":"GlobeNewswire","summary":"Hinge Bio Expands Leadership Team to Drive Clinical - GlobeNewswire","headline":"Hinge Bio Expands Leadership Team to Drive Clinical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPLWR3YmVTRC1DZ3pDbFJTakJTalJMYUdJYVM0UDgyVS1icXBmdWJfNDFrQkc4LVJaZ3B4VVlCV0xETHF1ZFpTbnRjNk1sakp3Yk5DRHVNN3F6R1VjbVhRZXc5S3dtOXUtS2djbXdfU2VoZ3ZDWUNPWWdRRkdaUmRXckRoN2dlek94NVFta0piSHo?oc=5","date":"2025-05-20","type":"pipeline","source":"thestreet.com","summary":"Key healthcare company files for Chapter 11 bankruptcy - thestreet.com","headline":"Key healthcare company files for Chapter 11 bankruptcy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE4zc1g2eVNFX2Q4emZnMUxQQ2lveVVhWmhYenVYZTcwREEzNm5OSXYzZXlIQ2lRVm9JcUIzZUlxYzh3MGJQR0UyOFlxX2hIdmZNN3Bz?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"MTEM Stock Price, News & Analysis - Stock Titan","headline":"MTEM Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPTUFzTHZTS3dJeTBoaFZqZWFKUnhsTmVycE1KdS13UXBqa2pTQnp5eEJzSEw1Mk5wLTFvODhnZ1c0cFNWTzFDU2ZEb25hV1dxcjF4M2lkTkJPTEEycEtiS1Y0OFJ6UHJYZk9GcGVWaUJXS3NKZG9EZGFZSVpWUzZDdkxrRy02OW40VmRkaW93RnJNaFV1MDUzcmpLcGVCSTJFVmE1US1UY2NjeERONHYwVVNCMGJSUQ?oc=5","date":"2025-04-24","type":"pipeline","source":"Investing.com","summary":"Molecular Templates enters bankruptcy, secures DIP financing - Investing.com","headline":"Molecular Templates enters bankruptcy, secures DIP financing","sentiment":"neutral"},{"date":"2025-04-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2025-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2025-01-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOdDhXY2RoZWRGN1BOeUZndEhqenk3dlU0LTJ2MmVBaXR5UnlPd0p3YzM2TDhibzJPNTBEQlprYlZwT2RRejVsNTdwZG1aUGtMMzUwNnlOYS1PaDk4RWRJTk05TS1mdy03X09Zb2gzZGk4YVIwRTltRGp1cWVGT3gzNzJRVjdoVzNrajdSM1k2V2dRc2kwU1lTanZyMXlTQ0JaeHVBYXhQZlJlN01BclI5Qmpic3pldFRweVZz?oc=5","date":"2024-12-19","type":"pipeline","source":"Stock Titan","summary":"Molecular Templates Faces Nasdaq Delisting After Multiple Compliance Failures - Stock Titan","headline":"Molecular Templates Faces Nasdaq Delisting After Multiple Compliance Failures","sentiment":"neutral"},{"date":"2024-12-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-12-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-12-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-11-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":3395000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":3395000,"period":"2017-12-31"},{"value":1880000,"period":"2016-12-31"},{"value":5089000,"period":"2011-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":48875000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-8124000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":11523000,"cashHistory":[],"totalAssets":35383000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}